4Bartolotta TV, Midiri M, Quaia E, etal. Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography [J]. Eur Radiol, 2005; 15(8): 1643
5Nicolau C, Catala V, Vilana R, et al . Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation [J]. Eur Radiol, 2004; 14(6) : 1092
6Park BK, Kim B, Kim SH, et al. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US [J]. Eur J Radiol, 2007,61(2) : 310
7de Groot MC, van Zwieten-Boot BJ, van Grootheest AC. Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent [J]. Ned Tijdschr Geneeskd, 2004; 148(38) : 1887
8Kupesic S, Kurjak A. Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses [EJ]. Obstet Gynecol, 2000; 96(3) : 452
9Bums PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast [J]. Invest Radiol, 2000,35(1) : 58
10Marret H, Sauget S, Giraudeau B, et al. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses [J]. J Ultrasound Med, 2004,23(12) : 1629
